IO Biotech Announces Presentation of New Data from MM1636 Phase 1/2 Clinical Trial Presented at 2022 AACR Annual Meeting
Источник:
Nasdaq GlobeNewswire
/
08 апр 2022 16:15:00 America/New_York
N/A
Опубликовать